| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 4.26 mm | 4.26 mm | 4.26 mm | 4.26 mm | 4.26 mm | 4.26 mm |
| Cash burn (monthly) | 805.67 k | 365.17 k | 8.86 mm | 3.74 mm | 2.10 mm | 1.41 mm |
| Cash used (since last report) | 4.08 mm | 1.85 mm | 44.89 mm | 18.96 mm | 10.61 mm | 7.15 mm |
| Cash remaining | 183.55 k | 2.41 mm | -40.63 mm | -14.69 mm | -6.35 mm | -2.89 mm |
| Runway (months of cash) | 0.2 | 6.6 | -4.6 | -3.9 | -3.0 | -2.0 |
| 13F holders | Current |
|---|---|
| Total holders | 20 |
| Opened positions | 5 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 2 |
| 13F shares | Current |
|---|---|
| Total value | 624.11 mm |
| Total shares | 8.72 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Factor Bioscience | 4.22 mm | $0.00 |
| Custard & Pitts Investment | 1.40 mm | $0.00 |
| Freebird Partners | 1.05 mm | $2.96 mm |
| Nicholas Jason Singer | 600.48 k | $0.00 |
| Iaf | 576.96 k | $1.04 mm |
| Purchase Capital | 280.42 k | $974.00 k |
| CI Private Wealth | 262.86 k | $276.01 mm |
| Cypress Point Wealth Management | 94.38 k | $99.09 mm |
| Naviter Wealth | 78.80 k | $82.74 mm |
| Sippican Capital Advisors | 68.50 k | $71.93 mm |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 7 Feb 25 | William A. Wexler | Stock Option Common Stock | Grant | Acquire A | No | No | 0.34 | 124,533 | 42.34 k | 124,533 |
| 7 Feb 25 | Gurrola Sandra M | Stock Option Common Stock | Grant | Acquire A | No | No | 0.34 | 150,000 | 51.00 k | 150,000 |
| 7 Feb 25 | Bristol James Arthur | Stock Option Common Stock | Grant | Acquire A | No | No | 0.34 | 72,074 | 24.51 k | 72,074 |
| 7 Feb 25 | Peter Cicala | Stock Option Common Stock | Grant | Acquire A | No | No | 0.34 | 51,485 | 17.50 k | 51,485 |
| 7 Feb 25 | Sanjeev Luther | Stock Option Common Stock | Grant | Acquire A | No | No | 0.34 | 1,123,350 | 381.94 k | 1,123,350 |
